WST R&D Expenses
West Pharmaceutical Services · R&D Expenses
WST R&D Expenses
Latest reported$74.40Mperiod ending
WST TTM R&D Expenses ($0.00 → $74.40M)
TTM R&D Expenses
High-resolution chart · PNG
WST r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 74,400,000 | |
| 73,800,000 | |
| 74,300,000 | |
| 71,000,000 | |
| 69,400,000 | |
| 67,800,000 | |
| 69,100,000 | |
| 69,000,000 | |
| 69,899,999 | |
| 68,899,999 | |
| 68,399,999 | |
| 65,899,999 | |
| 63,100,000 | |
| 61,000,000 | |
| 58,500,000 | |
| 56,300,000 | |
| 55,800,000 | |
| 55,200,000 | |
| 52,800,000 | |
| 52,000,000 | |
| 51,400,000 | |
| 48,400,000 | |
| 46,900,000 | |
| 44,200,000 | |
| 41,000,000 | |
| 39,800,000 | |
| 38,900,000 | |
| 38,500,000 | |
| 39,300,000 | |
| 40,500,000 | |
| 40,300,000 | |
| 40,200,000 | |
| 39,200,000 | |
| 38,400,000 | |
| 39,100,000 | |
| 39,000,000 | |
| 38,900,000 | |
| 37,700,000 | |
| 36,800,000 | |
| 37,200,000 | |
| 36,700,000 | |
| 36,000,000 | |
| 34,100,000 | |
| 31,900,000 | |
| 33,000,000 | |
| 34,800,000 | |
| 37,300,000 | |
| 39,200,000 | |
| 39,200,000 | |
| 38,800,000 | |
| 37,900,000 | |
| 36,800,000 | |
| 35,400,000 | |
| 34,100,000 | |
| 33,300,000 | |
| 31,900,000 | |
| 31,400,000 | |
| 30,500,000 | |
| 29,100,000 | |
| 28,800,000 | |
| 27,000,000 | |
| 25,400,000 | |
| 23,900,000 | |
| 22,800,000 | |
| 22,000,000 | |
| 21,000,000 | |
| 19,900,000 | |
| 18,000,000 | |
| 17,500,000 | |
| 17,700,000 | |
| 18,800,000 | |
| 19,500,000 | |
| 19,000,000 | |
| 17,900,000 | |
| 16,100,000 | |
| 11,500,000 | |
| 7,400,000 | |
| 3,600,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |